Search results for "Infections"
PASC defined, analyzed by latest COVID-19 studies
Two recent studies focused on postacute sequelae of SARS-CoV-2 (PASC), while another assessed the effectiveness of nirmatrelvir-ritonavir and molnupiravir in reducing morbidity and mortality from COVID-19.
https://immattersacp.org/weekly/archives/2023/06/06/2.htm
6 Jun 2023
ID, liver societies update guidance for HCV testing, management
Major changes to guidance on hepatitis C virus (HCV) include an emphasis on universal screening, new recommendations for managing incomplete treatment adherence, and expansion of treatment eligibility, among others.
https://immattersacp.org/weekly/archives/2023/06/06/1.htm
6 Jun 2023
Earn trust, counter misinformation
Physicians are on the front lines of addressing medical misinformation, increasingly figuring out what to address and how.
https://immattersacp.org/archives/2023/06/earn-trust-counter-misinformation.htm
1 Jun 2023
CBT improved severe fatigue after COVID-19, Dutch trial finds
After randomization, patients with severe fatigue three to 12 months after COVID-19 infection benefited from cognitive behavioral therapy (CBT) compared to usual care.
https://immattersacp.org/weekly/archives/2023/05/16/2.htm
16 May 2023
MKSAP Quiz: 8-week history of a spreading rash
A 63-year-old man is evaluated for an 8-week history of a spreading rash on the feet and legs, fatigue, and arthralgia. Following a physical exam and lab studies, what is the most likely diagnosis?
https://immattersacp.org/archives/2023/05/mksap-quiz-8-week-history-of-a-spreading-rash.htm
1 May 2023
Latest updates on ACP's priorities, initiatives
ACP Spotlight offers readers a look at ACP's current top priorities and initiatives, as well as highlights from our e-newsletter, ACP Internist Weekly.
https://immattersacp.org/archives/2023/05/latest-updates-on-acps-priorities-initiatives.htm
1 May 2023
Studies look at effectiveness of bivalent booster, fluvoxamine plus inhaled budesonide for COVID-19
After four weeks, bivalent booster vaccines were 47.5% effective against hospitalization or death from COVID-19, a study in North Carolina found, while a Brazilian trial showed that fluvoxamine plus inhaled budesonide significantly reduced the risk of progression to severe disease among high-risk patients with symptomatic COVID-19.
https://immattersacp.org/weekly/archives/2023/04/18/2.htm
18 Apr 2023
Large review compares benefits, harms of drugs to treat type 2 diabetes
High-certainty evidence indicated that sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists reduce all-cause death, while finerenone probably also reduced mortality based on moderate-certainty evidence.
https://immattersacp.org/weekly/archives/2023/04/18/4.htm
18 Apr 2023
MKSAP Quiz: Follow-up for kidney disease
A 31-year-old woman is evaluated during a follow-up visit for progressive autosomal dominant polycystic kidney disease and has a recent history of an infected kidney cyst. What is the most appropriate management?
https://immattersacp.org/weekly/archives/2023/04/11/3.htm
11 Apr 2023
MKSAP Quiz: Evaluation for fatigue, headache
A 36-year-old man is evaluated for fatigue, headache, myalgia, arthralgia, and sore throat of 2 days' duration. He is also seeking HIV pre-exposure prophylaxis initiation. Following a physical exam and lab tests, what is the most appropriate management?
https://immattersacp.org/weekly/archives/2023/04/04/3.htm
4 Apr 2023